Crinetics Pharmaceuticals (CRNX) Q2 2024 Earnings

May 9Confirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-1.01
-0.94
-0.88
-0.81

Details

Expected EPS
-0.809582
Actual EPS
-0.93
Surprise EPS
-0.12
Surprise Percent
-14.87%

Description

⁨Crinetics Pharmaceuticals⁩ (⁦CRNX⁩) has reported earnings of ⁦-0.93⁩ per share for ⁦Q2 2024⁩.

0 Comments

Share your thoughts